Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

5,575.00p
   
  • Change Today:
    -175.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 3,834.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 138,674
  • Market Cap: 3,666.45m
  • RiskGrade: 128

Deal with Barclays Trade now with Barclays Stockbrokers

Current

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-22 608.84 87.08 101.71p 54.8 68.3 +1% 33.63p 0.6%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (m)
30-Jun-2022 609 n/a n/a n/a n/a n/a
 
Earnings
30-Jun-2022 101.71p n/a n/a n/a n/a n/a
 
Dividend
30-Jun-2022 33.63p n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 3 0 0 0 0 0
Buy 1 0 0 0 0 0
Neutral 3 0 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 7 0 0 0 0 0
 
Average Rec 7.50 n/a n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 5,575.00p
Change Today -175.00p
% Change -3.04 %
52 Week High 6,070.00
52 Week Low 3,834.00
Volume 138,674
Shares Issued 65.77m
Market Cap 3,666.45m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.75% below the market average99.75% below the market average99.75% below the market average99.75% below the market average99.75% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
59.64% above the market average59.64% above the market average59.64% above the market average59.64% above the market average59.64% above the market average
58.06% above the sector average58.06% above the sector average58.06% above the sector average58.06% above the sector average58.06% above the sector average
Income
64.42% below the market average64.42% below the market average64.42% below the market average64.42% below the market average64.42% below the market average
63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average
Growth
84.16% above the market average84.16% above the market average84.16% above the market average84.16% above the market average84.16% above the market average
61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 18-Nov-21 04-Mar-21
Paid 10-Dec-21 01-Apr-21
Amount 21.70p 10.30p

Trades for 24-Sep-2021

Time Volume / Share Price
16:39 7,975 @ 5,581.97p
16:39 7,675 @ 5,581.97p
16:35 34,631 @ 5,575.00p
16:29 33 @ 5,605.00p
16:29 3 @ 5,600.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page